U.S. Markets close in 1 hr 7 mins

AtriCure, Inc. (ATRC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
40.24-0.54 (-1.32%)
As of 2:51PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close40.78
Open40.77
Bid40.23 x 1800
Ask40.30 x 1000
Day's Range40.17 - 41.15
52 Week Range22.57 - 51.76
Volume159,105
Avg. Volume368,512
Market Cap1.808B
Beta (5Y Monthly)0.74
PE Ratio (TTM)N/A
EPS (TTM)-1.28
Earnings DateOct 28, 2020 - Nov 02, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est55.63
  • AtriCure Announces Angie Wirick as Chief Financial Officer
    Business Wire

    AtriCure Announces Angie Wirick as Chief Financial Officer

    AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced today that Andy Wade is stepping down from the position of Chief Financial Officer (CFO) for personal reasons and moving into an advisory role through March 5, 2021. Angie Wirick, current Vice President of Finance, has been promoted to CFO effective immediately.

  • AtriCure Inc. (ATRC): Were Hedge Funds Right About Buying This Stock?
    Insider Monkey

    AtriCure Inc. (ATRC): Were Hedge Funds Right About Buying This Stock?

    We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]

  • Analysts Have Made A Financial Statement On AtriCure, Inc.'s (NASDAQ:ATRC) Second-Quarter Report
    Simply Wall St.

    Analysts Have Made A Financial Statement On AtriCure, Inc.'s (NASDAQ:ATRC) Second-Quarter Report

    AtriCure, Inc. (NASDAQ:ATRC) defied analyst predictions to release its second-quarter results, which were ahead of...